Procalcitonin is a Better Biomarker than C-Reactive Protein in Newborns Undergoing Cardiac Surgery: The Prokineca Study | Zendy

Sara BobilloPérez | Zendy; Javier RodríguezFanjul | Zendy; Iolanda Jordán | Zendy; J. Moreno Hernando | Zendy; Martín Iriondo Sanz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Procalcitonin is a Better Biomarker than C-Reactive Protein in Newborns Undergoing Cardiac Surgery: The Prokineca Study

Author(s) -

Sara BobilloPérez,

Javier RodríguezFanjul,

Iolanda Jordán,

J. Moreno Hernando,

Martín Iriondo Sanz

Publication year - 2016

Publication title -

biomarker insights

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.075

H-Index - 31

ISSN - 1177-2719

DOI - 10.4137/bmi.s40658

Subject(s) - procalcitonin , medicine , sepsis , c reactive protein , cardiac surgery , cardiopulmonary bypass , confidence interval , intensive care unit , prospective cohort study , biomarker , gastroenterology , anesthesia , surgery , inflammation , biochemistry , chemistry

To assess the kinetics of procalcitonin (PCT) and C-reactive protein (CRP) in newborns after cardiothoracic surgery (CS), with and without cardiopulmonary bypass, and to assess whether PCT was better than CRP in identifying sepsis in the first 72 hours after CS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research